Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Regeneron Pharmaceuticals Inc?

Accepted Answer

Según el último estado financiero (Form-10K), Regeneron Pharmaceuticals Inc tiene un total de activos de $37,759, una ganancia neta profit de $4,412

Question 2

¿Cuáles son los ratios financieros clave para REGN?

Accepted Answer

El ratio corriente de Regeneron Pharmaceuticals Inc es 4.49, el margen neto es 31.06, las ventas por acción son $123.38.

Question 3

¿Cómo se desglosan los ingresos de Regeneron Pharmaceuticals Inc por segmento o geografía?

Accepted Answer

Currently Regeneron Pharmaceuticals Inc data is not available.

Question 4

¿Es rentable Regeneron Pharmaceuticals Inc?

Accepted Answer

yes, según los últimos estados financieros, Regeneron Pharmaceuticals Inc tiene una ganancia neta profit de $4,412

Question 5

¿Tiene Regeneron Pharmaceuticals Inc alguna deuda?

Accepted Answer

yes, Regeneron Pharmaceuticals Inc tiene una deuda de 8,405

Question 6

¿Cuántas acciones en circulación tiene Regeneron Pharmaceuticals Inc?

Accepted Answer

Regeneron Pharmaceuticals Inc tiene un total de acciones en circulación de 109.6

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	14,247	14,202	13,117	12,172	16,071	8,497
Revenue Growth (YoY)	3%	8%	8%	-24%	89%	8%
Cost of Revenue	1,955	1,844	1,713	1,301	2,205	1,119
Gross Profit	12,292	12,357	11,403	10,871	13,865	7,377
Selling, General & Admin	3,196	2,954	2,631	2,115	1,824	1,441
Research & Development	5,156	5,132	4,439	3,592	2,864	2,650
Operating Expenses	8,358	8,139	7,068	5,618	4,643	3,810
Other Non Operating Income (Expenses)	38	15	-20	219	50	94
Pretax Income	5,145	4,779	4,199	4,858	9,325	3,810
Income Tax Expense	567	367	245	520	1,250	297
Net Income	4,578	4,412	3,953	4,338	8,075	3,513
Net Income Growth	-2%	12%	-9%	-46%	130%	66%
Shares Outstanding (Diluted)	107.2	115.1	113.7	113.5	112.2	115.1
Shares Change (YoY)	-8%	1%	0%	1%	-3%	0%
EPS (Diluted)	42.7	38.34	34.77	38.22	71.97	30.52
EPS Growth	7%	10%	-9%	-47%	136%	65%
Free Cash Flow	3,881	3,538	3,667	3,398	6,529	2,003
Free Cash Flow Per Share	36.2	30.73	32.25	29.93	58.19	17.4
Gross Margin	86.27%	87%	86.93%	89.31%	86.27%	86.81%
Operating Margin	27.6%	29.7%	33.04%	43.14%	57.38%	41.96%
Profit Margin	32.13%	31.06%	30.13%	35.63%	50.24%	41.34%
Free Cash Flow Margin	27.24%	24.91%	27.95%	27.91%	40.62%	23.57%
EBITDA	4,458	4,700	4,756	5,593	9,508	3,801
EBITDA Margin	31.29%	33.09%	36.25%	45.94%	59.16%	44.73%
D&A For EBITDA	525	482	421	341	286	235
EBIT	3,933	4,218	4,335	5,252	9,222	3,566
EBIT Margin	27.6%	29.7%	33.04%	43.14%	57.38%	41.96%
Effective Tax Rate	11.02%	7.67%	5.83%	10.7%	13.4%	7.79%

Regeneron Pharmaceuticals Inc (REGN) Price